Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Utility of positive controls in assessing assay sensitivity in ICH S7B and ICH E14 guidance for evaluation of QT/QTc interval prolongation.

Chiang AY, Mallinckrodt CH, Dmitrienko AA, Leishman DJ.

J Pharmacol Toxicol Methods. 2010 Sep-Oct;62(2):143-7. doi: 10.1016/j.vascn.2010.05.013. Epub 2010 Jun 4.

PMID:
20570744
2.

Heart rate-corrected QT interval in men increases during winter months.

Beyerbach DM, Kovacs RJ, Dmitrienko AA, Rebhun DM, Zipes DP.

Heart Rhythm. 2007 Mar;4(3):277-81. Epub 2006 Nov 17.

PMID:
17341387
3.

The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval.

Beasley CM Jr, Mitchell MI, Dmitrienko AA, Emmick JT, Shen W, Costigan TM, Bedding AW, Turik MA, Bakhtyari A, Warner MR, Ruskin JN, Cantilena LR Jr, Kloner RA.

J Am Coll Cardiol. 2005 Aug 16;46(4):678-87.

4.

Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma.

Bowton DL, Dmitrienko AA, Israel E, Zeiher BG, Sides GD.

J Asthma. 2005 Feb;42(1):65-71.

PMID:
15801331
5.

A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.

Bradley JD, Dmitrienko AA, Kivitz AJ, Gluck OS, Weaver AL, Wiesenhutter C, Myers SL, Sides GD.

J Rheumatol. 2005 Mar;32(3):417-23.

PMID:
15742431

Supplemental Content

Loading ...
Support Center